2006
Children's Yale-Brown Obsessive Compulsive Scale Modified for Pervasive Developmental Disorders
SCAHILL L, MCDOUGLE CJ, WILLIAMS SK, DIMITROPOULOS A, AMAN MG, MCCRACKEN JT, TIERNEY E, ARNOLD LE, CRONIN P, GRADOS M, GHUMAN J, KOENIG K, LAM KS, MCGOUGH J, POSEY DJ, RITZ L, SWIEZY NB, VITIELLO B. Children's Yale-Brown Obsessive Compulsive Scale Modified for Pervasive Developmental Disorders. Journal Of The American Academy Of Child & Adolescent Psychiatry 2006, 45: 1114-1123. PMID: 16926619, DOI: 10.1097/01.chi.0000220854.79144.e7.Peer-Reviewed Original ResearchConceptsChildren's Yale-Brown Obsessive Compulsive ScalePervasive developmental disorderYale-Brown Obsessive Compulsive ScaleRepetitive behaviorsYale-Brown Obsessive Compulsive Scale ModifiedDevelopmental disordersPediatric Psychopharmacology Autism NetworkLower adaptive functioningInternal consistencyMeasures of irritabilityMedication-free childrenExcellent internal consistencyObsessive Compulsive ScaleValidity of the Autism Diagnostic Interview-Revised
Lecavalier L, Aman MG, Scahill L, McDougle CJ, McCracken JT, Vitiello B, Tierney E, Arnold LE, Ghuman JK, Loftin RL, Cronin P, Koenig K, Posey DJ, Martin A, Hollway J, Lee LS, Kau AS. Validity of the Autism Diagnostic Interview-Revised. American Journal On Intellectual And Developmental Disabilities 2006, 111: 199-215. PMID: 16597187, DOI: 10.1352/0895-8017(2006)111[199:votadi]2.0.co;2.Peer-Reviewed Original Research
2003
Parent-Defined Target Symptoms Respond to Risperidone in RUPP Autism Study: Customer Approach to Clinical Trials
ARNOLD L, VITIELLO B, MCDOUGLE C, SCAHILL L, SHAH B, GONZALEZ N, CHUANG S, DAVIES M, HOLLWAY J, AMAN M, CRONIN P, KOENIG K, KOHN A, MCMAHON D, TIERNEY E. Parent-Defined Target Symptoms Respond to Risperidone in RUPP Autism Study: Customer Approach to Clinical Trials. Journal Of The American Academy Of Child & Adolescent Psychiatry 2003, 42: 1443-1450. PMID: 14627879, DOI: 10.1097/00004583-200312000-00011.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAffectAggressionAutistic DisorderChildClinical Trials as TopicDopamine AntagonistsDouble-Blind MethodEndpoint DeterminationFemaleHumansMaleObserver VariationParent-Child RelationsPlacebosResearch DesignRisperidoneSeverity of Illness IndexStereotyped BehaviorTreatment OutcomeConceptsAberrant Behavior Checklist-Irritability subscaleClinical trialsIrritability subscaleClinical Global Impression-ImprovementDouble-blind trialPediatric Psychopharmacology Autism NetworkChief complaintCommon symptomsTarget symptomsEfficacy assessmentIrritable behaviorSymptom categoriesRisperidoneChange scoresSymptomsEffect size dInterrater reliabilityTrialsPlaceboTreatment effectsClinical applicationPrimary measureConsumer-friendly wayWeeksAutism Network